Objectives: To measure incidence of conflicts of interest (COI) with food and pharmaceutical industry actors on the advisory committee for the 2020-2025 US Dietary Guidelines for Americans (DGA) and assess the adequacy of current mechanisms to disclose and manage COI among the committee's members.
Design: We compiled longitudinal data from archival sources on connections between members of the DGA's advisory committee and actors. We hypothesised that these committee members, who oversee the science for the most influential dietary policy in the USA, might have significant COI that would be relevant to their decision making.
Given the failures of the UN Food Systems Summit and Food and Agriculture Organization (FAO) to tackle the problems related to the corporate capture of food governance, this article calls for developing comprehensive legal frameworks for corporate accountability in food governance. In doing so, the authors identify key regulatory elements that need to be taken into account in food governance discussions. Their recommendations are borrowed from the guidance developed in the context of the negotiations for an International Legally Binding Instrument on TNCs and other Businesses with Respect to Human Rights, as well as in the WHO Framework Convention on Tobacco Control, the WHO Framework of Engagement with Non-State Actors, and the WHO Financial Regulations and Financial Rules.
View Article and Find Full Text PDF